314 — Sipai Health Technology Co, Balance Sheet
0.000.00%
- HK$1.74bn
- HK$1.07bn
- CNY4.57bn
Annual balance sheet for Sipai Health Technology Co,, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,671 | 1,608 | 1,531 | 1,130 | 920 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 182 | 401 | 440 | 587 | 571 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,292 | 2,488 | 2,695 | 2,442 | 1,980 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 90.3 | 114 | 88.9 | 81.1 | 57.7 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,479 | 2,893 | 2,930 | 2,815 | 2,265 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 613 | 831 | 1,055 | 1,142 | 1,037 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4,275 | 8,322 | 1,093 | 1,196 | 1,039 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -1,797 | -5,429 | 1,837 | 1,619 | 1,226 |
| Total Liabilities & Shareholders' Equity | 2,479 | 2,893 | 2,930 | 2,815 | 2,265 |
| Total Common Shares Outstanding |